Skip to main content

Table 2 Follow up patients’ characteristics stratified by type of mesh

From: Long-term outcomes of transvaginal mesh surgery for pelvic organ prolapse: a retrospective cohort study

Follow up patients’ characteristics

5 Years follow up characteristics (n = 210)

Comparison

Last follow up characteristics (n = 134)

Comparison

Mesh

Prolift (n = 94)

Gynemesh (n = 116)

P value

Prolift (n = 52)

Gynemesh (n = 82)

P value

Anterior Vaginal Wall prolapse stage (POP-Q), n (%)

0–1

87 (92.5%)

110 (94.8%)

0.496

49 (94.2%)

78 (95.1%)

0.821

 ≥ 2

7 (7.4%)

6 (5.2%)

3 (5.8%)

4 (4.9%)

Apical Vaginal Wall prolapse stage (POP-Q), n (%)

0–1

89 (94.7%)

104 (89.7%)

0.184

50 (96.2%)

78 (95.1%)

0.778

 ≥ 2

5 (5.3%)

12 (10.3%)

2 (3.8%)

5 (4.9%)

Posterior Vaginal Wall prolapse stage (POP-Q), n (%)

0–1

91 (96.8%)

111 (95.7%)

0.674

51 (98.1%)

80 (97.6%)

0.844

 ≥ 2

3 (3.2%)

5 (4.3%)

1 (1.9%)

2 (2.4%)

Repeated POP Surgery, n (%)

 

1 (1.1%)

3 (2.6%)

0.422

2 (3.8%)

3 (3.7%)

0.955

Mesh vaginal extrusion, n (%)

 

5 (5.3%)

6 (5.2%)

0.962

5 (9.6%)

7 (8.5%)

0.831

Vaginal bleeding, n (%)

 

2 (2.1%)

2 (1.7%)

0.832

3 (5.8%)

4 (4.9%)

0.821

Pain#, n (%)

 

4 (4.3%)

7 (6.0%)

0.565

2 (3.8%)

3 (3.7%)

0.955

Urinary Incontinence, n (%)

 

13 (13.8%)

11 (9.5%)

0.325

3 (5.8%)

5 (6.1%)

0.938

Urinary tract infection, n (%)

 

5 (5.3%)

7 (6.0%)

0.824

3 (5.8%)

6 (7.3%)

0.727

Subsequent MUS surgery, n (%)

 

5 (5.3%)

3 (2.6%)

0.304

1 (1.9%)

3 (3.7%)

0.565

  1. #Pelvic pain or dyspareunia